Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CANCEROMICS

Financiado

Cerrado

Modelling cancer in Caenorhabditis elegans

Cancer is a complex disease that results from accumulation of diverse alterations in the genome. There are more than 300 genes identified as cancer genes although it is estimated that there are many more involved in cancer develop... ver más

31/03/2012

FUNDACIO INSTITUT...

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 16M€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2012-03-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

FUNDACIO INSTITUT D?INVESTIG...

0.00€ | Lider

FUNDACIO HOSPITAL UNIVERSITA...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

SAF2015-67919-R CROMATINA, ARN NO CODIFICANTE Y CANCER 157K€ Cerrado

SAF2012-37252 SWI/SNF, MICRORNAS AND CANCER. 117K€ Cerrado

PHENOSPACE Quantifying behavioural phenotype space chemistry to gene s... 2M€ Cerrado

SAF2016-76758-R ESTUDIO MOLECULAR DE LOS MECANISMOS RESPONSABLES DEL PAPEL D... 145K€ Cerrado

Oncoworm ONCOWORM Using functional genomics in highly regenerative f... 195K€ Cerrado

SAF2012-31627 CARACTERIZACION MOLECULAR DEL PAPEL DE LOS COMPLEJOS REMODEL... 140K€ Cerrado

Líder del proyecto

FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 16M€

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is a complex disease that results from accumulation of diverse alterations in the genome. There are more than 300 genes identified as cancer genes although it is estimated that there are many more involved in cancer development that could be significant during tumorigenesis and putative targets for drugs therapies. Several scientific groups are performing a comprehensive sequencing of genes in cancer cells but these studies lack of functional validation. Since cancer requires the combination of several defects in the genome, an organism amenable for genetics and functional genomics studies as Caenorhabditis elegans would provide the ideal platform to identified those fatidic combinations. I plan to take advantage of C. elegans mutants and a RNA interference (RNAi) library to uncover functions and pathways of the following C. elegans genes: A) SWI/SNF complex subunit ZK1128.5 baf-60: The SWI/SNF complex is conserved from yeast to humans and acts in chromatin remodelling to regulate gene expression. baf-60 mutants present extra proliferation at particular lineages. B) Claspin, F25H5.5: Human Claspin acts as a DNA damage checkpoint through the activation of chk1 protein kinase. chk-1 also acts as a DNA damage checkpoint in C. elegans. I have preliminary results in C. elegans pointing to a novel role of Claspin in genome stability. C) Spliceosome (or splicing-related) components rsr-2 and lsm-2: I have recently published that rsr-2 and lsm-2 act in the RAS pathway that determine the vulval cell fate in C. elegans (Ceron et al, 2007). This observation and others suggests functional relationships between spliceosome-related genes and cancer. The discovery of functional networks for these genes will contribute to create a Functional map for cancer genes that will be a essential toward understanding this complex disease and, ultimately, find effective therapies.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores